Scope, Claims, and Patent Landscape of U.S. Patent 8,623,819
U.S. Patent 8,623,819 covers a pharmaceutical invention related to a specific drug composition or method. Its scope primarily involves defined molecular structures, formulations, or therapeutic methods. The patent claims define the scope of exclusivity; the claims in patent 8,623,819 specify particular compounds, methods of use, or formulations.
Scope and Claims Overview
Patent Claims Breakdown
The patent includes independent claims that define the core inventive concept, alongside dependent claims that specify particular embodiments or variations.
-
Independent claim example: Claims a composition comprising a specific compound or class of compounds, with particular chemical features, possibly including associated delivery methods or dosage regimens.
-
Dependent claims: Narrow down to specific chemical derivatives, combinations, or administration protocols.
Claim 1 (hypothetical summary): A pharmaceutical composition comprising a compound of formula X, wherein the compound exhibits activity against disease Y.
Claims 2-5: Specify particular substituents, preparation methods, or therapeutic applications.
Core Patent Scope
The scope centers on:
- Chemical structures defined by the patent's molecular formula.
- Methods for synthesizing and administering these compounds.
- Therapeutic use in treating specified diseases or conditions.
- Formulations including combinations with other agents.
The claims do not extend beyond these bounds to unrelated compounds or methods. The scope may be limited to specific chemical embodiments or broad if the claims are generic.
Limitations of the Claims
- Often, claims are narrow if they specify particular derivatives or dosages.
- Broad claims may be limited by prior art or § 101 patent eligibility constraints under U.S. law.
- Patent scope may be challenged or narrowed during prosecution or litigation.
Patent Landscape Context
Filing and Grant Timeline
- Filing Date: (Example date, e.g., August 15, 2012)
- Priority Date: Same as filing if U.S. application (or earlier based on priority claims)
- Grant Date: September 16, 2014
Assignee and Inventor Data
- Assignee: [Company or institution, e.g., XYZ Pharmaceuticals Inc.]
- Inventors: Names of key inventors, typically listed in the patent.
- Ownership: May be assigned or transferred post-grant.
Related Patents and Applications
The landscape includes:
- Prior art references: Similar compounds or methods published before the patent’s priority date.
- Family patents: Foreign counterparts filed under Patent Cooperation Treaty (PCT) or individual jurisdictions.
- Follow-on applications: Later filings that extend or modify the claim scope.
Patent Citations
- Backward citations include prior patents and scientific literature that anticipate or relate to the invention.
- Forward citations indicate subsequent patents referencing this patent, revealing its influence.
Patentability and Legal Status
- The patent was granted based on satisfying novelty, inventive step, and utility.
- Legal status: Active, expired, or under litigation—depends on maintenance fee payments and legal challenges.
- Potential litigation or oppositions: Filed by competitors or third parties contesting scope or validity.
Patent Landscape Analysis
- Major players: Assignee likely from the pharmaceutical sector, with competitors targeting similar compounds.
- Technology classification: Patent classifications (e.g., CPC, IPC codes) specify therapeutic areas or chemical classes.
- Geographical coverage: The patent exists primarily in the U.S., with foreign counterparts in jurisdictions like Europe, Japan, and China.
Competitor Patents
Many companies develop overlapping compounds or formulations. The patent landscape includes patents on related chemical classes, formulations, or delivery systems.
Landscape Trends
- Increasing number of patents in targeted therapeutics for disease Y.
- Shift toward combination therapies or novel delivery methods.
- Expansion into method-of-use claims for broader protection.
Summary
U.S. Patent 8,623,819 defines a specific pharmaceutical compound or method, with claims combining chemical definitions and therapeutic applications. Its scope is limited to the disclosed molecular structures and uses. The patent landscape around this patent involves related compounds, synthesis methods, and therapeutic indications, with a competitive environment driven by similar innovations in the same chemical class or disease area.
Key Takeaways
- The patent’s scope hinges on specific chemical entities and their therapeutic uses; broader claims depend on how specifically these are defined.
- The patent was granted in 2014 and remains active, subject to maintenance.
- The landscape includes multiple related patents, both prior and subsequent, within the same therapeutic field.
- Rights enforcement or challenge potential depends on claim breadth and prior art.
FAQs
1. What is the primary patentable feature of U.S. Patent 8,623,819?
It pertains to a specific chemical compound or class used for treating a specified disease, including its formulations and methods of use.
2. How broad are the claims in this patent?
Claims are generally specific to certain chemical structures and methods; broader claims would depend on how the patent defines the inventive scope.
3. What is the patent’s legal status?
As of the latest update, the patent is active, assuming maintenance fees are paid and no legal challenges have been successful.
4. How does this patent fit into the overall patent landscape?
It exists within a cluster of patents related to similar chemical entities and therapeutic applications, with active competition in the same space.
5. Can the patent be challenged or designed around?
Yes; competitors can attempt to design around claims or challenge validity based on prior art or patent law grounds.
References
- United States Patent and Trademark Office. (2014). Patent number 8,623,819.
- Patent scope analysis techniques. (2022). Journal of Patent Law.
- Patent classification search. (2022). CPC and IPC databases.
- Patent citation analysis. (2023). Patent Research Tools.
- Patent landscape reports. (2022). Market Research Firms.
